Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 10, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 14, 2026
CEOIndirect holdingOther
Context
Classification
other
Code P in the derivative table; not an open-market share purchase
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001493152-26-051920
Filed / recorded
Nov 14, 2026, 2:59 AM UTC
Added to OQRO
Nov 14, 2026, 3:00 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
NEXGEL, INC.
Issuer CIK
1468929
Ticker
NXGL
Reporting person
Brian Joseph Kieser
Relationship
Director, Officer, 10% owner
Officer title
Interim CEO
Security
Warrant to Purchase Common Stock (the "PIPE Warrant")
Table
Derivative (Table II)
Transaction date
Nov 10, 2026
Transaction code
P
Shares / units
133,216
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
133,216
Ownership form
Indirect — By Sequence LifeScience, Inc.
Amendment
No
Footnotes from the filing
Reflects the purchase by Sequence LifeScience, Inc. ("Sequence") on November 10, 2026 of 133,216 units from the Issuer, each unit consisting of one share of Common Stock and a warrant to purchase one share of Common Stock (the "PIPE Warrant"), at $5.50 per unit, in a private placement under a Securities Purchase Agreement. No separate consideration was paid for the PIPE Warrant. The closing occurred on November 10, 2026. The PIPE Warrant has an original issue date of November 10, 2026, is exercisable for cash at $10.00 per share, and expires on the fifth anniversary of its original issue date. The Issuer has waived the beneficial-ownership limitation that would otherwise apply to these securities.
The securities are held of record by Sequence. The Reporting Person is the indirect sole owner of Sequence and may be deemed to have voting and investment power over the securities held by Sequence. The Reporting Person disclaims beneficial ownership of the securities held by Sequence except to the extent of his pecuniary interest therein.
Bought outside the usual windowTraded Nov 10 · filed 4 days later
A Nexgel director paid $25K out of pocket for Nexgel shares. 1 other person at Nexgel bought some too, in the same month. It was the first purchase in 24 months.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.